Get your Journal for ImmunoTherapy of Cancer paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.2
Authored by Sumalatha Gangadhar | Published on 17 August, 2026
Submitting to Journal for ImmunoTherapy of Cancer goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Journal for ImmunoTherapy of Cancer guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Journal for ImmunoTherapy of Cancer. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Journal for ImmunoTherapy of Cancer journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Journal for ImmunoTherapy of Cancer guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Journal for ImmunoTherapy of Cancer guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through ScholarOne (Manuscript Central).
| Element | J ImmunoTherapy Cancer requirement |
|---|---|
| Abstract | Abstract requirements vary by article type: (1) Case Reports: Unstructured abstract, 100-200 words, followed by a mandatory 1-3 sentence statement of clinical or biologic insight. (2) Commentaries: Up to 200 words (editorials do not require abstracts). (3) Hypotheses: Up to 200 words. (4) Letters: No abstract. (5) Original Research: Structured abstract, 250-350 words with mandatory sections: Background, Methods, Results, Conclusions. (6) Position Articles and Guidelines: Up to 350 words. (7) Reviews: Up to 350 words. (8) Short Reports: Up to 350 words |
| Main text | Main text word limits by article type (excludes title page, abstract, tables, acknowledgements, contributions and references): Case Reports 500-2,500 words; Commentary/Editorials up to 1,500 words; Hypotheses up to 1,500 words (ideally 500-1,500); Letters up to 1,500 words; Original Research up to 5,000 words (4,000-5,000); Position Articles and Guidelines up to 8,000 words; Reviews: Conventional types up to 5,000 words, Mini-Reviews up to 3,000 words; Short Reports up to 2,500 words (1,500-2,500) |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | Three to ten keywords representing the main content of the article |
| References | Vancouver style. References are sequentially numbered within the text of the main document and match the reference list at the end of the article |
| Peer review | Single anonymised peer review (also called single-blind) whereby the names of the reviewers are hidden from the author; this is the traditional method of reviewing and is the most common |
| Submission | mc.manuscriptcentral.com/jitc |
Read the Journal for ImmunoTherapy of Cancer guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Journal for ImmunoTherapy of Cancer in under a page.
Skim two or three recent J ImmunoTherapy Cancer papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Journal for ImmunoTherapy of Cancer journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Journal for ImmunoTherapy of Cancer guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through ScholarOne (Manuscript Central).